Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evasc Medical Systems develops innovative endovascular devices for the treatment of cerebral aneurysms, particularly targeting challenging wide-neck bifurcation cases. Their flagship technology—the eCLIPs Bifurcation Aneurysm Remodeling System—has demonstrated superior clinical outcomes and safety profiles compared to previous standards. The second-generation device offers improved deliverability and procedural efficiency. Ongoing multicenter clinical trials are evaluating its technical feasibility, safety, and efficacy across Europe; initial results indicate comparable or better occlusion rates than competing devices with rapid placement times.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evasc Medical Systems.